PROVECTUS BIOPHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Knoxville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
PROVECTUS BIOPHARMACEUTICALS, INC. has filed 1,077 SEC EDGAR filings since 31 Mar 2000

SEC filing history

Showing 26-50 of 803 matching filings.

Per page
25
Current page
2
PRE 14A File 001-36457

PRE 14A

Filing date
20 Apr 2026
Reporting date
20 Apr 2026
Next action
Verify source filing
4

4

Filing date
06 Apr 2026
Reporting date
04 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Mar 2026
Reporting date
25 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Mar 2026
Reporting date
20 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Mar 2026
Reporting date
12 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Mar 2026
Reporting date
05 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Feb 2026
Reporting date
26 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Feb 2026
Reporting date
20 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Feb 2026
Reporting date
19 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Feb 2026
Reporting date
12 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Feb 2026
Reporting date
09 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Feb 2026
Reporting date
05 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Feb 2026
Reporting date
30 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Jan 2026
Reporting date
28 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Jan 2026
Reporting date
16 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Dec 2025
Reporting date
11 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Dec 2025
Reporting date
05 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-32172

SCHEDULE 13D filing

Filing date
08 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-32172

SCHEDULE 13D/A filing

Filing date
01 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Nov 2025
Reporting date
26 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Nov 2025
Reporting date
20 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
14 Nov 2025
Reporting date
13 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .